Jon Alexander Schwartz
Directeur Technique/Scientifique/R&D chez Nanospectra Biosciences, Inc.
Profil
Jon Alexander Schwartz is currently the Director-Clinical Research at Nanospectra Biosciences, Inc. He has an undergraduate and graduate degree from Rice University and a doctorate from the University of Texas Graduate School of Biomedical Sciences.
Postes actifs de Jon Alexander Schwartz
| Sociétés | Poste | Début |
|---|---|---|
Nanospectra Biosciences, Inc.
 Nanospectra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Nanospectra Biosciences, Inc. provides commercializing particle-based therapies the selective and precise thermal destruction of solid tumors. It develops AuroLase Therapy utilizing AuroShell Particles (also referred to as nanoshells) for the precise, particle-based thermal ablation of solid tumors. The company was founded by Naomi J. Halas, Jennifer L. West, and Daniel M. Watkins in 2002 and is headquartered in Houston, TX. | Directeur Technique/Scientifique/R&D | 13/06/2013 |
Formation de Jon Alexander Schwartz
| Rice University | Graduate Degree |
| University of Texas Graduate School of Biomedical Sciences | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Nanospectra Biosciences, Inc.
Nanospectra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Nanospectra Biosciences, Inc. provides commercializing particle-based therapies the selective and precise thermal destruction of solid tumors. It develops AuroLase Therapy utilizing AuroShell Particles (also referred to as nanoshells) for the precise, particle-based thermal ablation of solid tumors. The company was founded by Naomi J. Halas, Jennifer L. West, and Daniel M. Watkins in 2002 and is headquartered in Houston, TX. | Health Technology |
